Glial hyaluronate-binding protein in Wallerian degeneration of dog spinal cord.
Wallerian degeneration of spinal cord dorsal columns was produced in three dogs by unilateral extradural dorsal rhizotomy at the lower thoracic level. The spinal cord was studied 1 month, 2 months, and 3 months after surgery. Transverse cryostat sections at the site rhizotomy and at the mid-thoracic level were stained by indirect immunofluorescence with antibodies to the glial fibrillary acidic protein (GFAP) and to the glial hyaluronate-binding protein (GHAP). GHAP immunoreactivity was almost unchanged in the degenerated dorsal column 1 month after rhizotomy. After 2 and 3 months, staining with GHAP antibodies was markedly decreased in the gliosed dorsal column at the site of rhizotomy, but it still persisted at the mid-thoracic level. It is concluded that GHAP persists for long periods of time in dorsal columns undergoing Wallerian degeneration, a finding consistent with its putative role as a nonpermissive substrate preventing nerve regeneration in CNS white matter.
Bignami
A
A
Spinal Cord Injury, Research Laboratory, Veterans Administration Medical Center, Boston, Massachusetts 02132.
Mansour
H
H
Dahl
D
D
D000818:Animals; D002352:Carrier Proteins / Q000378:metabolism*; D004285:Dogs; D005904:Glial Fibrillary Acidic Protein / Q000378:metabolism; D018960:Hyaluronan Receptors; D007150:Immunohistochemistry; D009410:Nerve Degeneration / Q000502:physiology*; D009457:Neuroglia / Q000378:metabolism* / Q000502:physiology; D013116:Spinal Cord / Q000166:cytology / Q000378:metabolism* / Q000502:physiology; D014855:Wallerian Degeneration / Q000502:physiology*
D002352:Carrier Proteins; D005904:Glial Fibrillary Acidic Protein; D018960:Hyaluronan Receptors